top of page
Train is a spin-out from IRCCS Humanitas Research Hospital founded in 2023. Our mission is to enable clinical trial innovation and personalized medicine through generative AI. Our competitive advantage is the clinical validation and the scientific evidence achieved through our collaborations with domain experts within the hospital.
Our Creative Founders.
We’re led by a diverse group of visionary leaders who bring together cutting-edge innovation, expertise in AI, and deep experience in medical science.
CSO
Prof. Matteo Della Porta
Head of leukemia unit at Humanitas CSO and co-founder of Train.
bottom of page